Bronchodilator medicines - Clinical trials 

Clinical trials for Bronchodilator medicines

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Bronchodilator medicines. For all clinical trials, go to clinical trials search

This list shows clinical trials for Bronchodilator medicines

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Bronchodilator medicines
Title Recruitment status Location
A comparison of devices for measurement of spirometry in normal healthy subjects and patients with respiratory disease Recruiting United Kingdom
Evaluation of current Triage methods during a flu pandemic Recruiting United Kingdom
A study of early continuous positive airways pressure in acute respiratory failure in children with impaired immunity Recruiting United Kingdom
Assessment of Ventilation-Perfusion Abnormalities in Patients With Stable Smoking-Related Airways Disease Recruiting United Kingdom
An Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Asthma Recruiting United Kingdom
A double-blind, placebo-controlled efficacy (as assessed by post-bronchodilator FEV1) and safety study of 5 mg RO3300074 once-daily for 2 years in subjects with smoking-related, moderate-to-severe COPD with emphysema receiving concurrent optimal COPD drug therapy. Not Recruiting United Kingdom
A double-blind, placebo-controlled efficacy (as assessed by post-bronchodilator FEV1) and safety study of 5 mg RO3300074 once-daily for 2 years in subjects with smoking-related, moderate-to-severe COPD with emphysema receiving concurrent optimal COPD drug therapy. Not Recruiting United Kingdom
Determining the optimal approach to identifying individuals with chronic obstructive pulmonary disease Not recruiting United Kingdom
The Bronchodilator Effect of Ultrafine Particles of Salbutamol Not recruiting United Kingdom
Biomarkers to target antibiotics and steroid therapy in chronic obstructive pulmonary disease (COPD) exacerbations Not recruiting United Kingdom